A. Pang

Co-carcinogenesis and field cancerization: oral lesions offer first signs.

S. Lippman, C. Flaitz, R. Devoll, 1995, Journal of the American Dental Association.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, W. Hong, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

S. Lippman, J. Lee, R. Morice, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

S. Lippman, W. Hong, H. Libshitz, 1992, Journal of the National Cancer Institute.

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non‐small cell lung cancer

S. Lippman, H. Libshitz, F. Fossella, 1991, Cancer.

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

S. Lippman, F. Fossella, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy

W. Hong, J. S. Lee, W. Murphy, 2004, Cancer Chemotherapy and Pharmacology.

Resectability of Small‐Cell Lung Cancer Following Induction Chemotherapy in Patients with Limited Disease (Stage II‐IIIb)

W. Hong, J. Roth, R. Komaki, 1991, American journal of clinical oncology.

Phase I studies of gemcitabine

S. Lippman, F. Fossella, J. Abbruzzese, 1993 .